Trial Profile
Randomised Controlled Trial on Efficacy and Safety of Short Term Versus Long Term Antibiotic [ceftibuten]Therapy for Pyelonephritis in Childhood.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 31 Oct 2012
Price :
$35
*
At a glance
- Drugs Ceftibuten (Primary)
- Indications Bacterial infections; Pyelonephritis
- Focus Therapeutic Use
- Acronyms STUTI
- 16 Feb 2012 Actual patient number 26 added as reported by ClinicalTrials.gov.
- 16 Feb 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 18 Aug 2008 New trial record.